Literature DB >> 8248998

Discrete cortical infarction with prominent impairment of thumb flexion.

Y Terao1, H Hayashi, T Kanda, H Tanabe.   

Abstract

BACKGROUND: Intracortical efferent zones in the primary motor cortex for thumb movements, namely thumb flexion, extension, adduction, and abduction, have been described in Macaca mulatta monkeys but not in humans. Even recent cortical mapping based on intraoperative monitoring does not provide information about intracortical efferent zones as it is not ethically possible to search the human motor cortex extensively by punctate electrodes. CASE DESCRIPTION: A 78-year-old man with discrete cortical embolism over the left central sulcus is described. Only a mild weakness of his right thumb was observed. Thumb flexion was affected to a greater degree than thumb extension, adduction, and abduction. The lesion ran along the bottom of the central sulcus and affected part of the precentral and postcentral gyri on both sides of it. Animal studies in Macaca mulatta monkeys have shown that the intracortical efferent zones for thumb movement, especially for thumb flexion, are located in the part of the motor cortex just adjoining the central sulcus that folds down from the "bank" to the depth of the central sulcus. It was possible to explain the prominent weakness of thumb flexion if we applied the results of the animal studies.
CONCLUSIONS: Our case suggests that the same arrangement of intracortical efferent zones found in monkeys may also exist in human beings.

Entities:  

Mesh:

Year:  1993        PMID: 8248998     DOI: 10.1161/01.str.24.12.2118

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  1 in total

1.  A case report of isolated distal upper extremity weakness due to cerebral metastasis involving the hand knob area.

Authors:  András Folyovich; Viktória Varga; György Várallyay; Lajos Kozák; Mária Bakos; Erika Scheidl; Katalin Anna Béres-Molnár; Zita Kajdácsi; Dániel Bereczki
Journal:  BMC Cancer       Date:  2018-10-03       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.